Progressive Care Inc.
Announces Record Number
of Prescriptions Filled and
Strong Revenues
During August
2018
MIAMI,
FL. -- September
18,
2018 -- InvestorsHub NewsWire -- Progressive Care Inc.
(OTCQB:
RXMD),
a personalized
healthcare
services and technology company,
today announced further
growth year-over-year in both revenue and number of prescriptions
filled for August 2018. In
August, the company reported a total of $1.93
million in net revenue, a 3% increase from the same month last
year, and a 44%
increase in prescriptions filled during
the same month last year, totaling just
over 29,000
filled
prescriptions.
Progressive Care's
wholly-owned subsidiary PharmCo, LLC saw a record month
for
prescriptions
filled in August, reporting a 30% increase in prescriptions
filled over the same month last year, totaling more than 26,200 prescriptions.
The
company's newest PharmCo Rx 1002 facility reported just over 2,700 prescriptions filled during the
month of August and approximately $116,000 in revenue. Since
completing the acquisition of the
Touchpoint pharmacy last month, Progressive Care
has increased the involvement of its own management at the
new
location to
ensure it will
continue to have a significant contribution on the company's
ongoing expansion plans for the remainder of 2018 and well into the
following year.
"We are proud to announce
another month of significant growth for Progressive
Care. The
strong sales and prescription numbers reported for August serve as
a testament to the increased value we continue to deliver to not
only our shareholders, but also to our growing network of patients,
physicians, and providers," said S. Parikh Mars, Chief Executive
Officer of Progressive Care Inc.
Mars
continued: "As we head into the end of
2018, Progressive Care will keep taking the necessary steps
to execute its growth and expansion plans. In addition
to aggressively
increasing our management team's involvement at the new pharmacy
location to
ensure it will have a greater impact on prescriptions
filled and reported revenue in future
months, the
company will also continue to build out its healthcare technology offering
through the development of our own proprietary Tele-Pharmco
software and
ongoing updates to the new PharmCo website."
The
release of the company's August
2018 sales
figures follows the recent launch of
PharmCo's newly redesigned website, which aims to provide patients with a better
understanding of the company's
products and
services, as well as offer an online resource platform for
healthcare stakeholders to better understand Progressive Care's
model and how it delivers leading performance and
results.
Earlier
this month, Progressive
Care announced that
its Chief Executive Officer would be speaking on the
"Global vs. Local" panel
at
the first FlyPharma
conference
in the United States, which took place September
11-12th
in
Miami, Florida. The company also announced media coverage it has
received in top trade publications for its efforts to battle the opioid
epidemic and
its strong expertise in
healthcare technology.
For
more information about Progressive Care, please visit the
company's website.
Connect
and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD), through its PharmCo, LLC, is a South Florida health
services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking
Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information currently available to the Company and are subject
to a number of risks, uncertainties, and other
factors that could cause the Company's actual results, performance,
prospects, and opportunities to differ materially from those
expressed in, or implied by, these forward-looking
statements.
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Tory
Patterson, CMW Media
Tory@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Progressive Care (QB) (USOTC:RXMD)
Historical Stock Chart
From Sep 2023 to Sep 2024